ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,128Medicare Part D Prescriptions Filled, Including Refills

Rank: 336 out of 1121

$529K Total Retail Price of All Prescriptions

Rank: 374 out of 1121

200 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 200 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

32% of this provider’s 200 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 8,489 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

51 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
HYDROCODONE-ACETAMINOPHEN 622 528 S3 1 3
FUROSEMIDE 363 312 2 7
DONEPEZIL HCL 278 276 3 35
LEVOTHYROXINE SODIUM 258 220 4 2
WARFARIN SODIUM 248 246 5 11
AMLODIPINE BESYLATE 236 225 6 5
SIMVASTATIN 233 183 7 1
LISINOPRIL 219 168 8 4
METOPROLOL TARTRATE 215 187 9 9
CITALOPRAM HBR 178 143 10 18
JANTOVEN 174 153 11 146
SERTRALINE HCL 172 144 12 21
POTASSIUM CHLORIDE 148 136 13 12
GABAPENTIN 146 123 14 13
OMEPRAZOLE 138 124 15 6
RISPERIDONE 137 136 16 82
NAMENDA 132 132 17 53
LANTUS 128 98 18 52
SEROQUEL 125 120 19 134
QUETIAPINE FUMARATE 105 88 20 75
DIOVAN 101 101 21 45
TAMSULOSIN HCL 100 88 22 32
CYMBALTA 95 67 23 50
DIVALPROEX SODIUM 94 75 24 98
CARVEDILOL 89 77 25 20
TRAZODONE HCL 88 67 26 40
TRAMADOL HCL 87 85 27 25
FAMOTIDINE 80 55 28 63
OXYCODONE HCL 79 0 S2 29 68
HYDRALAZINE HCL 79 35 29 66
LACTULOSE 79 62 29 132
PREDNISONE 77 76 32 43
MIRTAZAPINE 76 71 33 56
EXELON 75 75 34 119
ALBUTEROL SULFATE 73 20 35 141
DIGOXIN 73 73 35 59
KLOR-CON 10 71 56 37 69
CARBIDOPA-LEVODOPA 71 71 37 118
ROPINIROLE HCL 71 53 37 91
FENTANYL 69 45 S2 40 100
PROMETHAZINE HCL 67 51 R 41 67
CLOPIDOGREL 66 58 42 27
METFORMIN HCL 65 52 43 8
LOSARTAN POTASSIUM 65 64 43 17
PAROXETINE HCL 64 43 45 58
RIVASTIGMINE 63 63 46 273
ISOSORBIDE MONONITRATE ER 62 53 47 62
LEXAPRO 62 62 47 218
NOVOLOG 61 35 49 139
LEVETIRACETAM 59 58 50 125
HYDROCHLOROTHIAZIDE 59 43 50 10
IPRATROPIUM-ALBUTEROL 58 54 52 160
PLAVIX 55 47 53 42
CLONIDINE 53 41 54 304
METOCLOPRAMIDE HCL 52 38 55 120
SPIRIVA 52 47 55 49
CIPROFLOXACIN HCL 51 45 57 57
LYRICA 50 33 58 76
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.